The Cooper Companies, Inc. (NASDAQ:COO) Holdings Cut by Blair William & Co. IL

Blair William & Co. IL reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.4% during the 4th quarter, HoldingsChannel reports. The fund owned 39,337 shares of the medical device company’s stock after selling 1,365 shares during the period. Blair William & Co. IL’s holdings in Cooper Companies were worth $3,616,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. NEOS Investment Management LLC raised its position in Cooper Companies by 24.7% during the fourth quarter. NEOS Investment Management LLC now owns 6,252 shares of the medical device company’s stock valued at $575,000 after acquiring an additional 1,237 shares in the last quarter. UniSuper Management Pty Ltd increased its stake in shares of Cooper Companies by 30.5% during the 4th quarter. UniSuper Management Pty Ltd now owns 24,294 shares of the medical device company’s stock worth $2,233,000 after purchasing an additional 5,672 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 1.5% during the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock valued at $460,066,000 after purchasing an additional 74,501 shares in the last quarter. Elo Mutual Pension Insurance Co boosted its holdings in Cooper Companies by 11.8% in the fourth quarter. Elo Mutual Pension Insurance Co now owns 19,767 shares of the medical device company’s stock worth $1,819,000 after purchasing an additional 2,080 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Cooper Companies by 3.5% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 306,992 shares of the medical device company’s stock worth $28,179,000 after buying an additional 10,428 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Up 0.7 %

Shares of COO opened at $84.35 on Tuesday. The company has a 50-day simple moving average of $89.15 and a 200-day simple moving average of $97.03. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38. The firm has a market capitalization of $16.87 billion, a P/E ratio of 43.26, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on COO. Morgan Stanley decreased their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Wells Fargo & Company increased their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.